A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Introduction to City of Hope
City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
City of Hope Locations

City of Hope is committed to making the process of becoming a patient here as easy as possible. Call 800-826-HOPE (4673) or complete the Schedule a Callback form.
As an leader in cancer research, our goal is to bring the latest scientific findings into medical practice as quickly as possible.
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena.
  • A team of City of Hope researchers has received a two-year, $1 million Movember-Prostate Cancer Foundation (PCF) Challenge Award for a double-armed project to treat advanced prostate cancer. The team will be studying two novel agents’ promising ability to stage a combined immunotherapeutic attack against prostate cancer cells, which have previously been resistant to such an effort.
  • The funding, made possible by philanthropic support, will be used to recruit highly experienced and well-published scientists to join the Department of Diabetes and Metabolic Diseases Research at Beckman Research Institute of City of Hope. Their areas of research will include cell biology, immunology, diabetic complications, gene regulation and obesity— all fields that will be integral in develo...
  • Yuman Fong, M.D., an internationally recognized expert in hepatobiliary cancer and in the use of genetically modified viruses to combat malignant disease, has been named chair of the Department of Surgery at City of Hope. Fong comes to City of Hope from Memorial Sloan Kettering Cancer Center in New York, where he held for the last 14 years the Murray F. Brennan Chair in Surgery and Professorship in su...
  • A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds’ effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
  • The gift was announced Jan. 11 at a gala at City of Hope, which culminated a year-long celebration of the institution’s centennial and the start of a new century of discovery. The gift will enable City of Hope researchers, already national leaders in the treatment of blood and bone marrow diseases, to deepen their investigation of the biological mechanisms of lymphoma, identify new molecular tar...
  • Five foundations — Alex’s Lemonade Stand Foundation, Pediatric Cancer Research Foundation (PCRF), The Matthew Larson Foundation for Pediatric Brain Tumors — and two anonymous foundations have announced grants totaling $450,000 in support of Dr. Margarita Gutova’s work, allowing her to continue her preclinical studies using neural stem cells to treat medulloblastoma.
  • Noted business leader and physician Norman C. Payson, M.D., has been selected as the new chair of the City of Hope board of directors. He began his three-year term on Jan. 1, taking helm of the institution’s board as the research and treatment center launches a new era of growth and scientific investment.
  • City of Hope has earned two prestigious Press Ganey awards for its top-quality patient care, marking its fifth consecutive year of being honored by the healthcare industry’s leading performance improvement firm. This week, City of Hope received both the Guardian of Excellence Award and the Beacon of Excellence Award.